Functions of Lipids for Enhancement of Oral Bioavailability of Poorly Water-Soluble Drugs 727 [44] Alleman E, Gurny R, Doelker E. Drug-loaded nanoparticles – preparation methods and drug targeting issues. Eur J Pharm Biopharm. 1993; 39: 173–191. [45] Reithmeier H, Herrmann J, Gopferich A. Development and characterization of lipid microparticles as a drug carrier for somatostatin. Int J Pharm. 2001; 218: 133–143. http://dx.doi.org/10.1016/S0378-5173(01)00620-2 [46] Hu F, Yuan H, Zhang H. Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int J Pharm. 2002; 239: 121–128. http://dx.doi.org/10.1016/S0378-5173(02)00081-9 [47] Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery; drug incorporation and physicochemical characterization. J Microencapsul. 1999; 16: 205–213. http://dx.doi.org/10.1080/026520499289185 [48] Venkateswarlu V, Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release. 2004; 95: 627–638. http://dx.doi.org/10.1016/j.jconrel.2004.01.005 [49] Zur MA, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery- Drug release and release mechanism. Eur J Pharm Biopharm. 1998; 45: 149–155. http://dx.doi.org/10.1016/S0939-6411(97)00150-1 [50] Hou D, Xie C, Huang K. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials. 2003; 24: 1781–1785. http://dx.doi.org/10.1016/S0142-9612(02)00578-1 [51] Constantinides P. Lipid microemulsion for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects. Pharm Res. 1995; 12: 1561–1572. http://dx.doi.org/10.1023/A:1016268311867 Sci Pharm. 2011; 79: 705–727